| Hammond Power Solutions Announces Retirement of Lead Director |
Globe Newswire |
10/19 |
07:00 |
| MC Brazil Downstream Trading S.à r.l. Announces Increase in Tender Offer Consideration and Total Consideration in Connection with Its Tender Offer for Any and All of Its Outstanding 7.250% Senior Secured Notes Due 2031 and Related Consent Solicitation |
Globe Newswire |
10/19 |
07:00 |
| PyroGenesis Receives $2.3 Million Payment Under Existing $25+ Million Drosrite™ Contract with Saudi Client |
Globe Newswire |
10/19 |
07:00 |
| Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics |
Globe Newswire |
10/19 |
07:00 |
| Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Tigo Energy, Inc. (TYGO), Fluence Energy, Inc. (FLNC), and Anavex Life Sciences Corp. (AVXL) Announced by Holzer & Holzer, LLC |
Globe Newswire |
10/19 |
07:00 |
| EquipmentShare Raises 2026 Financial Outlook on Strong Performance and Customer Demand |
Globe Newswire |
10/19 |
07:00 |
| Plug Power Appoints Dr. Lee Sweetland as Global Engineering Industrialization Lead |
Globe Newswire |
10/19 |
07:00 |
| Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM |
Globe Newswire |
10/19 |
07:00 |
| Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar |
Globe Newswire |
10/19 |
07:00 |
| Gogo unveils Galileo roadmap to continue enhancing customer investments through the mid 2030s and beyond |
Globe Newswire |
10/19 |
07:00 |
| Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP) |
Globe Newswire |
10/19 |
07:00 |
| Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026 |
Globe Newswire |
10/19 |
07:00 |
| Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer |
Globe Newswire |
10/19 |
07:00 |
| EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD |
Globe Newswire |
10/19 |
07:00 |
| Ethyreal Bio Achieves Proof of Mechanism in First-in-Human Study of ETHY-001 and Initiates First Patient Cohorts to Advance Development in Thyroid Eye Disease (TED) and Graves’ Disease (GD) |
Globe Newswire |
10/19 |
07:00 |
| Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Lincoln Educational Services (LINC), FuelCell Energy, Inc. (FCEL), and AST SpaceMobile, Inc. (ASTS) Announced by Holzer & Holzer, LLC |
Globe Newswire |
10/19 |
07:00 |
| Owlting Group (NASDAQ: OWLS) Issues CEO Letter to Shareholders Marking One Year on Nasdaq |
Globe Newswire |
10/19 |
06:58 |
| RETEVIS Marks 16 Years, Advancing Reliable Industrial Communication Solutions |
Globe Newswire |
10/19 |
06:56 |
| YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST |
Globe Newswire |
10/19 |
06:55 |
| BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026 |
Globe Newswire |
10/19 |
06:45 |
| Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site |
Globe Newswire |
10/19 |
06:45 |
| Scorpio Tankers Inc. Announces that on October 28, 2026, the Company Plans to Issue Its Third Quarter 2026 Results and Have a Conference Call |
Globe Newswire |
10/19 |
06:44 |
| Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany |
Globe Newswire |
10/19 |
06:30 |
| CBIZ Reports Third-Quarter and Nine Months Ended September 30, 2026 Financial Results |
Globe Newswire |
10/19 |
06:30 |
| Washington Bets $4.2 Billion on Nuclear. Elon Musk Is Betting on the Sun. |
Globe Newswire |
10/19 |
06:30 |
